Dipyridamole myocardial perfusion single photon emission computed tomography in patients with slow coronary flow

Coronary Artery Disease

Volumn 13, Issue 4, 2002, Pages 223-229

  Demirkol, Mehmet O ^a   Yaymaci, Bengi ^a   Mutlu, Bülent ^a  

^a NONE   (Turkey)

Author keywords

Coronary arteriography; Coronary slow flow; Dipyridamole; Myocardial perfusion single photon emission computed tomography

Indexed keywords

CONTRAST MEDIUM; DIPYRIDAMOLE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD FLOW VELOCITY; BLOOD VESSEL TONE; CORONARY ARTERY BLOOD FLOW; EXERCISE TEST; FEMALE; HEART MUSCLE PERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY DISEASE; DIPYRIDAMOLE; EXERCISE TEST; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCARDIUM; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VASODILATOR AGENTS;

EID: 0036620296     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200206000-00004     Document Type: Article

References (14)

1. Van Lierde J, Vrolix M, Sionis D, De Geest H, Piessens J. Lack of evidence for small vessel disease in a patient with "slow dye progression" in the coronary arteries. Cathet Cardiovasc Diagn 1991; 23:117-120.
2. Tambe AA, Demany MA, Zimmerman HA, Mascarenhas E. Angina pectoris and slow flow velocity of dye in coronary arteries. A new angiographic finding. Am Heart J 1972; 84:66-71.
3. Mangieri E, Macchiarelli G, Ciavolella M, Barilla F, Avella A, Martinotti A, et al. Slow coronary flow: clinical and histopathologic features in patients with otherwise normal epicardial coronary arteries. Cathet Cardiovasc Diag 1996; 37:375-381.
4. Mosseri M, Yarom R, Gotsman MS, Hasin Y. Histologic evidence for small vessel coronary artery disease in patients with angina pectoris and patient large coronary arteries. Circulation 1986; 74:964-972.
5. Ciavolella M, Avella A, Bellagamba S, Mangieri E, Nigri A, Reale A. Angina and normal epicardial coronary arteries radionuclide features and pathophysiological implications at long term follow up. Coron Artery Dis 1994; 5:493-499.
6. Cesar LAM, Ramires JAF, Serrano CV Jr, Meneghetti JC, Antonelli RH, da-Luz PL, et al. Slow coronary run-off in patients with angina pectoris: clinical significance and thallium-201 scintigraphic study. Braz J Med Biol Res 1996; 29:605-613.
7. Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B, Marble SJ, et al. TIMI frame count. A quantitative method of assessing coronary artery flow. Circulation 1996; 93:879-888.
8. Berman DS, Kiat H, Friedman JD, Wang FP, Van Train K, Matzer L, et al. Separate acquisition rest thallium-201/stress technetium sestamibi dual isotope myocardial perfusion single photon emission computed tomography: a clinical validation study. J Am Coll Cardiol 1993; 22:1455-1464.
9. Kemp HG, Kronmal RA, Vliestra RE, Frye RL. Seven year survival of patients with normal or near normal coronary arteriograms: a CASS registry study. J Am Coll Cardiol 1986; 7:479-483.
10. Fam WM, McGregor M. Effect of nitroglycerin and dipyridamole on regional coronary resistance. Circ Res 1968; 22:649-659.
11. Sellke FW, Myers PR, Bates JN, Harrison DG. Influence of vessel size on the sensitivity of porcine coronary microvessels to nitroglycerin. Am J Physiol 1990; 258:H515-H520.
12. Disalvo TG. Dipyridamole. in: Messerli FH, editor. Cardiovascular drug therapy. 2nd ed. Philadelphia: Saunders; 1996. p. 1451.
13. Chilian WM, Layne SM, Klausher EC, Eastham CL, Marcus ML. Redistribution of coronary microvascular resistance produced by dipyridamole. Am J Physiol 1989; 236:H383-H390.
14. Kurtoglu N, Akcay A, Dindar I. Usefulness of oral dipyridamole therapy for angiographic slow coronary artery flow. Am J Cardiol 2001; 87:777-779.